Originally published

Adipose SIRT1, eNAMPT secretion and hypothalamic NAD+ in mice

English editorial edition · GAAH Science


Adipose SIRT1, eNAMPT secretion and hypothalamic NAD+ in mice

Two forms of NAMPT

Nicotinamide phosphoribosyltransferase, or NAMPT, is an enzyme involved in NAD+ biosynthesis. In mammals it is discussed in intracellular and extracellular forms, often abbreviated iNAMPT and eNAMPT.

This study examined how adipose tissue regulates NAMPT secretion and how that may contribute to communication between tissues. It is not a study of NMN purification, despite an unrelated purification-paper heading attached to the Japanese archive.

SIRT1 and the regulation of secretion

The researchers reported that deacetylation of intracellular NAMPT by SIRT1 promoted its secretion from adipocytes. Acetylation is a chemical modification of a protein; changing it can influence the protein's function or its interaction with other molecules.

The paper therefore investigated a regulated process, rather than assuming that intracellular and circulating NAMPT always have the same activity or biological role.

What was observed in adipose cells

The archive describes secretion from differentiated brown and white adipocytes. Extracellular NAMPT showed approximately two- to four-fold higher enzyme activity than the intracellular form in the cited comparisons.

NAMPT acetylation in adipose tissue fell in response to fasting in an experimental setting. The investigators also used differentiated HIB-1B brown adipocytes, which express and secrete NAMPT, to examine how post-translational changes affected secretion and enzyme activity.

A specific lysine residue

One focus was lysine 53, written as K53. Experimental substitutions at this site helped investigate whether its acetylation state influenced the fate of the protein. K-to-R, K-to-Q and K-to-A variants produced observations consistent with a role for this site in secretion or activity.

The study identified several acetylation sites, with differences between intracellular and extracellular NAMPT. The authors proposed that conformational changes or interactions with unidentified factors might help explain how acetylation regulates the enzyme.

A possible feedback system between tissues

SIRT1 and NAMPT had already been connected with rhythms in NAD+ metabolism. This work suggested an additional feedback process involving the secretion of eNAMPT from adipose tissue and NAD-related regulation elsewhere, including the hypothalamus in the animal experiments.

The findings emphasize tissue communication and the response to nutrient availability. They do not show that increasing an oral NMN dose reproduces an engineered change in NAMPT secretion.

Interpreting the study

Enzyme regulation can depend on location, chemical modification and the physiological state of the organism. These findings help explain that complexity. They are not evidence that a finished supplement improves hypothalamic function or extends human life.

Research discussed in the archive: SIRT1-mediated eNAMPT secretion from adipose tissue and the regulation of hypothalamic NAD+ in mice. The unrelated size-exclusion-chromatography heading in the original article has not been used as its bibliographic attribution.

Back to the research library